PETVW | PetVivo Holdings, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.0499 - 0.0499
52 Week Range	0.0499 - 0.0499
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	23,874
Average Volume	N/A
Shares Outstanding	183,911,182
Market Cap	9,177,168
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2021-08-11

Valuation
Profitability
Growth
Health
P/E Ratio	-0.10
Forward P/E Ratio	N/A
EPS	-0.48
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	20
Country	USA
Website	PETVW

PetVivo Holdings, Inc., a veterinary biotech and biomedical device company, engages in the licensing and commercializing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Kush, a veterinarian-administered joint injection for the treatment of osteoarthritis and lameness in dogs and horses. The company's pipeline products include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Minneapolis, Minnesota.

PETVW's peers: NMTC, NSYS, CEADW, KWESW, NXLIW

*Chart delayed

Analyzing fundamentals for PETVW we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see PETVW Fundamentals page.

Watching at PETVW technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on PETVW Technicals page.